Cardiosonic develops solutions for transluminal, high-intensity ultrasound ablation. The company's flagship application, the TIVUS high-intensity, directional ultrasound catheter system, enables remote, localized, controlled, and repeatable thermal modulation of the renal vessel wall tissue, to perform safe, therapeutic renal sympathetic denervation by ultrasound ablation for resistant hypertension.
The TIVUS system consists of the TIVUS catheter and the TIVUS control console. Ultrasound waves are transmitted from the tip of the TIVUS catheter through the arterial wall to ablate the surrounding renal nerves. Renal nerve ablation resets the body's sympathetic tone/drive and results in blood pressurereduction. The TIVUS console enables the interventionalist to control the parameters (e.g. treatment intensity and duration) of the treatment, which lasts less than 10 minutes.